Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases

KPJ van Dam, L Wieske, EW Stalman… - European Journal of …, 2024 - Wiley Online Library
Background and purpose There are concerns for safety regarding SARS‐CoV‐2 vaccines
for patients with autoimmune neuromuscular disease. We compared daily functioning using …

COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus

M Dey, B Doskaliuk, J Lindblom, E Nikiphorou… - Journal of Clinical …, 2023 - mdpi.com
Background: The safety profile of COVID-19 vaccination is well documented, but hesitancy
among people with immune-mediated inflammatory diseases, often immunocompromised …

Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

S Ahmed, L Gupta, M Kuwana, JD Pauling… - Rheumatology …, 2024 - Springer
This study aimed to assess the incidence, predictors, and outcomes of breakthrough
infection (BI) following coronavirus disease (COVID-19) vaccination in patients with systemic …

Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group

R Shumnalieva, N Ravichandran… - … journal of rheumatic …, 2024 - Wiley Online Library
Background Despite the overall safety and efficacy of COVID‐19 vaccinations, rare cases of
systemic autoimmune diseases (SAIDs) have been reported post‐vaccination. This study …

Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends

X Kong, W Wang - Rheumatology & Autoimmunity, 2024 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) vaccination in patients with
rheumatic disease is of practical clinical importance. This study aimed to perform a …